Related Experiment Videos
Effect of peritoneal cells on tumors cells growth in vitro
1Department of Tumor Immunology, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Abstract:
The cytotoxic and cytostatic activity of PMA-treated macrophages, obtained from pristane-primed BALB/c mice, was analyzed in vitro. The activated macrophages were cytotoxic and cytostatic for YAC-1 lymphoma, P-388 leukemia and P-815 mastocytoma target cells. However, the RPC-5 plasmacytoma target cells appeared to be resistant to their cytotoxicity. The observed cytotoxic or cytostatic effects of macrophages in vitro were not correlated with their ability to produce the superoxide ion. Cytotoxic activity of NK cells, obtained from pristane-primed mice, was also studied. No differences in cytotoxicity of NK cells obtained from pristane-treated and untreated donors, were found. However, only the effector cells from untreated mice were able to respond to stimulatory effect of polyinosinic acid-polycytidylic acid-poly-L-lysine (poly ICLC).
Insights
Pristane-primed macrophages showed cytotoxic and cytostatic effects against specific cancer cells, but not all. Natural killer (NK) cell activity was unaffected by pristane priming.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Macrophages and Natural Killer (NK) cells are key immune components.
- Pristane is known to induce immune responses.
- Understanding immune cell activity is crucial for cancer therapy.
Purpose of the Study:
- To investigate the cytotoxic and cytostatic activity of pristane-primed macrophages.
- To evaluate the impact of pristane priming on NK cell cytotoxicity.
- To explore the correlation between macrophage activity and superoxide production.
Main Methods:
- Culturing and treating BALB/c mice macrophages with phorbol 12-myristate 13-acetate (PMA).
- Assessing macrophage cytotoxicity and cytostasis against YAC-1 lymphoma, P-388 leukemia, P-815 mastocytoma, and RPC-5 plasmacytoma cells in vitro.
- Measuring superoxide ion production by macrophages.
- Analyzing NK cell cytotoxicity from pristane-treated and untreated mice.
- Testing NK cell response to polyinosinic acid-polycytidylic acid-poly-L-lysine (poly ICLC).
Main Results:
- PMA-activated macrophages from pristane-primed mice exhibited cytotoxic and cytostatic effects on YAC-1, P-388, and P-815 cells.
- RPC-5 plasmacytoma cells were resistant to the cytotoxic effects of these activated macrophages.
- No correlation was found between the cytotoxic/cytostatic effects of macrophages and their superoxide ion production.
- No significant differences in NK cell cytotoxicity were observed between pristane-treated and untreated donors.
- NK cells from untreated mice responded to poly ICLC stimulation, while those from pristane-primed mice did not.
Conclusions:
- Pristane priming enhances macrophage-mediated cytotoxicity and cytostasis against certain tumor cell lines.
- RPC-5 plasmacytoma cells display resistance to activated macrophages.
- Superoxide production is not the primary mechanism for the observed macrophage-induced cytotoxicity.
- Pristane priming does not enhance NK cell cytotoxicity but may impair their responsiveness to specific immune stimulants like poly ICLC.